Zhou Y - Search Results

1

Clinical and pathological studies of borderline gastrointestinal stromal tumors.

Shi Y, Hou YY, Lu SH, Zhou Y, Xu JF, Ji Y, Hou J, Xu C, Liu YL, Tan YS, Zhu XZ. Shi Y, et al. Among authors: zhou y. Chin Med J (Engl). 2010 Sep;123(18):2514-20. Chin Med J (Engl). 2010. PMID: 21034620

2

Stage and histological grade of gastrointestinal stromal tumors based on a new approach are strongly associated with clinical behaviors.

Hou YY, Lu SH, Zhou Y, Qi WD, Shi Y, Tan YS, Zhu XZ. Hou YY, et al. Among authors: zhou y. Mod Pathol. 2009 Apr;22(4):556-69. doi: 10.1038/modpathol.2009.11. Epub 2009 Feb 27. Mod Pathol. 2009. PMID: 19252472 Free article.

3

Impact of KIT and PDGFRA gene mutations on prognosis of patients with gastrointestinal stromal tumors after complete primary tumor resection.

Hou YY, Grabellus F, Weber F, Zhou Y, Tan YS, Li J, Shen KT, Qin J, Sun YH, Qin XY, Bockhorn M, Gerken G, Broelsch CE, Frilling A. Hou YY, et al. Among authors: zhou y. J Gastrointest Surg. 2009 Sep;13(9):1583-92. doi: 10.1007/s11605-009-0842-6. Epub 2009 Mar 17. J Gastrointest Surg. 2009. PMID: 19291337

4

Imatinib mesylate neoadjuvant treatment for rectal malignant gastrointestinal stromal tumor.

Hou YY, Zhou Y, Lu SH, Qi WD, Xu C, Hou J, Tan YS. Hou YY, et al. Among authors: zhou y. World J Gastroenterol. 2009 Apr 21;15(15):1910-3. doi: 10.3748/wjg.15.1910. World J Gastroenterol. 2009. PMID: 19370794 Free PMC article.

5

[Study on the mechanism of imatinib-induced resistance in gastrointestinal stromal tumors].

Zhou Y, Hou YY, Tan YS, Lu SH, Hou J, Liu JL, Qin J, Shen KT, Sun YH. Zhou Y, et al. Zhonghua Zhong Liu Za Zhi. 2009 Aug;31(8):597-601. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 20021947 Chinese.

6

[Study on clinicopathologic parameters of malignant behavior in gastrointestinal stromal tumors].

Hou YY, Zhu XZ, Lu SH, Zhou Y, Hou J, Tan YS, Shen KT, Qin J, Sun YH. Hou YY, et al. Among authors: zhou y. Zhonghua Bing Li Xue Za Zhi. 2010 May;39(5):325-31. Zhonghua Bing Li Xue Za Zhi. 2010. PMID: 20654156 Chinese.

7

[Application of cell block technology in pathologic diagnosis of hematolymphiod neoplasms].

Shi Y, Hu Q, Zhou Y, Hou YY, Sun LD, Xie HX, Sujie A, Tan YS. Shi Y, et al. Among authors: zhou y. Zhonghua Bing Li Xue Za Zhi. 2010 Aug;39(8):553-4. Zhonghua Bing Li Xue Za Zhi. 2010. PMID: 21055036 Chinese. No abstract available.

8

[Role of heterogeneous nuclear ribonucleoprotein A2/B1 protein in the pathogenesis of non-small cell lung cancer].

Shi Y, Chen Y, Hou YY, Ji CH, Hu Q, Zhou Y, Su JA, Tan YS. Shi Y, et al. Among authors: zhou y. Zhonghua Zhong Liu Za Zhi. 2011 Feb;33(2):110-4. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 21575478 Chinese.

9

Synchronous and metachronous multiple gastrointestinal stromal tumors.

Xu C, Liu YL, Yu HY, Hou YY, Lu SH, Zhao LJ, Zhou Y, Shi Y, Tan YS, Zhu XZ. Xu C, et al. Among authors: zhou y. Histol Histopathol. 2012 Feb;27(2):225-34. doi: 10.14670/HH-27.225. Histol Histopathol. 2012. PMID: 22207557

10

Hepatic pseudolymphoma: imaging features on dynamic contrast-enhanced MRI and diffusion-weighted imaging.

Zhou Y, Wang X, Xu C, Zhou G, Zeng M, Xu P. Zhou Y, et al. Among authors: zhou g. Abdom Radiol (NY). 2018 Sep;43(9):2288-2294. doi: 10.1007/s00261-018-1468-5. Abdom Radiol (NY). 2018. PMID: 29392361

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,620 results

Search Page

Filters